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Highlights 
 Biodegradable poly(L-lactide) matrix loaded with ZnO nanorods. 
 Dynamic presentation of nanorods triggered by PLLA degradation. 
 Changes in surface properties as a function of time control cell behaviour. 
 Nanorods exposure promotes cell differentiation.  
 
 
  
    
3 
 
Keywords: PLLA, ZnO nanoparticle, C2C12 myoblast, nanocomposite, cell differentiation 
 
Abstract  
This work investigates the effect of the sequential availability of ZnO nanoparticles, 
(nanorods of ~ 20 nm) loaded within a degradable poly(lactic acid) (PLLA) matrix, in cell 
differentiation. The system constitutes a dynamic surface, in which nanoparticles are exposed 
as the polymer matrix degrades. ZnO nanoparticles were loaded into PLLA and the system 
was measured at different time points to characterise the time evolution of the 
physicochemical properties, including wettability and thermal properties. The micro and 
nanostructure were also investigated using AFM, SEM and TEM images. Cellular 
experiments with C2C12 myoblasts show that cell differentiation was significantly enhanced 
on ZnO nanoparticles – loaded PLLA, as the polymer degrades and the availability of 
nanoparticles become more apparent, whereas the release of zinc within the culture medium 
was negligible. Our results suggest PLLA/ZnO nanocomposites can be used as a dynamic 
system where nanoparticles are exposed during degradation, activating the material surface 
and driving cell differentiation.   
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1. Introduction  
Poly(lactic acid) (PLLA) is a semicrystalline, [1] aliphatic polyester extensively used in tissue 
engineering for many reasons; it is a biodegradable thermoplastic that presents 
biocompatibility, very low toxicity and can be shaped into different forms. [2-5] Numerous 
authors have modified PLLA to improve its characteristics for scaffolding in tissue 
engineering; to this purpose, PLLA has been blended with other polymers or inorganic 
materials to create composites. Different inorganic materials have been used such as 
hydroxyapatite (HAp), [6, 7] carbon nanotubes (CNTs), [8-10] bioactive glasses [11, 12] or metallic 
nanoparticles (NPs) [13, 14].  
NPs are promising aspirants to be used in nanomedicine; because of their small size they can 
work at the scale of biomolecules, allowing more specific interactions with cells. [15, 16]  
Particularly, NP–loaded systems enhance cellular processes in vitro. For example, PLLA/iron 
oxide nanocomposites have shown neurite extension in electrospun microfibers,  Cai et al. 
showed that PLLA/Fe3O4 composites enhanced osteogenic differentiation 
[17] and in a similar 
way Dong et al. showed enhanced osteogenic differentiation with PLLA/dicalcium silicate 
fibres. [18]  
In this context, ZnO NPs have attracted attention as antimicrobials [19, 20] and UV blockers, [21] 
among others. Moreover, zinc is an essential element for cells, which acts as an intracellular 
secondary messenger in different cellular processes, [22, 23] in particular, the lack of zinc can 
inhibit myoblast differentiation. [24, 25] More recently has been shown that zinc promotes 
myoblast proliferation and differentiation via the activation of the ERK/Akt signalling 
cascade. [26] ZnO NPs have demonstrated their preferential ability to kill high proliferative 
cells, like cancer cells, versus normal cells. [19, 27] In addition, the oxidative stress properties 
of ZnO NPs have been also tested; [28] ZnO NPs can be sequestered by autophagy and this 
internalization could generate reactive oxygen species (ROS) intracellularly. [29] The effect of 
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surfaces containing ZnO in cell behaviour has been investigated previously. Osteoblast 
adhesion has been shown to be elevated on ZnO surfaces with high roughness (~ 30 nm), 
prepared by compression of ZnO NPs. [30] ZnO nanorod-coated surfaces were shown to be 
cytotoxic to macrophages regardless of the underlying topography [31] and has been reported 
to be cytotoxic to neuroblastoma cells and vascular endothelial cells with similar Zn 
concentrations (~150 µM). [32, 33]A recent study showed that electrospun nanofibres of 
ZnO/TiO2 NPs resulted in increased cell proliferation of C2C12 myoblasts, although cell 
differentiation was not addressed. [13] 
In this work, ZnO NPs have been loaded into a PLLA matrix to promote cell differentiation. 
We used C2C12 myoblasts because of their differentiation potential towards osteogenic and 
myogenic lineages [34] and the suggested role of zinc in myoblast differentiation. [26]  We 
show that NPs are not released into the culture medium at the timescale we work with, but 
they are available on the material surface as time progresses. These changes in surface 
physicochemical properties, while the presentation of the nanoparticle is taking place, is 
enough to trigger higher cellular processes, such as cell differentiation.  
2. Experimental section 
2.1. Sample preparation 
Samples were prepared by solvent-precipitation followed by compression moulding. First, 
ZnO NPs (L´Urederra technological centre (ES), rod-shaped structure with 43 ± 24 nm 
dimensions in length as measured in a previous work) [35] were homogeneously suspended in 
chloroform (LabScan, ≥ 99.8%) via mild-sonication (20% output for 5 min, Vibra-CellTM CV 
334) and added to previously dissolved PLLA (Purac Biochem (NL), number-average 
molecular weight (Mn) of 100 kDa and polydispersity index (Mw/Mn) of 1.85), at a 
concentration of 1wt. %. Another sonication step during 10 min was applied to disperse the 
NPs before precipitation in methanol (Panreac (ES), ≥ 99.5%) excess. This method ensures a 
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homogeneous distribution of NPs within the polymer matrix. After drying the resulting 
materials for 72 h at 70 ºC in a vacuum-oven, films with a thickness of ~150 µm were 
fabricated in a hydraulic hot press by compression moulding at 190 ºC for 4 min under a 
pressure of 150 MPa. Subsequently, films were water quenched to avoid the development of 
large crystalline fractions. 
2.2. Transmission electron microscopy (TEM) 
ZnO NPs were analyzed under transmission electron microscopy (TEM). A droplet of diluted 
suspension (0.1% (w/w)) in chloroform was deposited on carbon-coated grids. TEM was 
carried out using a Philips CM120 Biofilter apparatus with STEM module at an acceleration 
voltage of 120 kV. Images were acquired with a Morada digital camera. 
2.3. Field Emission Scanning Electron Microscopy (FESEM) 
Nanoparticle dispersion studies within the polymeric matrix were performed in a Hitachi S-
4800 field emission scanning electron microscope (FE-SEM) at an acceleration voltage of 5 
kV. Cryogenically fractured surfaces were cobalt-coated in a Quorum Q150T ES turbo-
pumped sputter coater (5 nm thick coating). 
2.4. Atomic force microscopy (AFM) 
Surface topology features were analyzed using a Dimension ICON atomic force microscope 
(AFM) from Bruker (Bruker Corporation, Coventry, UK). Experiments were carried out in 
tapping mode with an integrated silicon tip/cantilever. Surface roughness of specimens was 
quantified by both root mean square roughness (Rq) and mean roughness (Ra) parameters as 
follows: 
𝑅𝑞 = √
∑ (𝑍𝑖−𝑍𝑎𝑣𝑒)
2𝑁
𝑖=1
𝑁
     (1) 
  𝑅𝑎 =
∑ |𝑍𝑖−𝑍𝑐𝑝|
𝑁
𝑖=1
𝑁
     (2) 
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Where Zave is the average Z value within the analyzed area, N is the number of points, Zi is 
the current Z value and Zcp is the Z value of the centre plane. 
Mechanical properties of the films were obtained by indentation tests. Samples were probed 
using a JPK NanoWizard III Atomic Force Microscope (JPK instruments AG, Berlin (DE)) 
with a pyramidal-shaped silica tip/cantilever (ACTA probes, AppNano, CA, US). The probe 
was calibrated using the thermal fluctuation method obtaining a nominal spring constant of ~ 
40 N/m. Force indentation curves were obtained using the force mapping mode over areas of 
30 µm2 (25 measurements per map, n > 100 curves). A force of 4 µN with a constant speed 
(2.5 µm/s) was applied to obtain approximately 50 nm indentation. Each indentation curve 
was analysed using the Hertzian model for a pyramidal tip (JPK software, spm-4.3.50) from 
which the Young’s modulus values were calculated. The Poisson’s ratio for incompressible 
materials was used (ν = 0.5). 
 
2.5. Wide angle X-ray diffraction (WAXD) 
Wide angle X-ray diffraction (WAXD) was conducted to elucidate the crystalline structure of 
ZnO nanoparticles. X-ray powder diffraction patterns were collected in a PHILIPS X’PERT 
PRO automatic diffractometer in theta-theta configuration, secondary monochromator with 
Cu-Kα radiation (λ = 1.5418 Å) and a PIXcel solid state detector. The sample was mounted 
on a zero background silicon wafer fixed in a generic sample holder. Data were collected 
from 20 to 75° 2θ (step size = 0.026) at room temperature (RT). 
2.6. Hydrolytic degradation  
150 µm thick square-shaped specimens were hydrolytically degraded at 37 ºC in a Phosphate 
Buffer solution (PBS, Sigma (UK); pH=7.4) and were removed after different periods of 
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time. The pH evolution of the medium was monitored using a 691 pH Meter (Metrohm). 
Water absorption (WA) and remaining weight (RW) values were determined according to: 
𝑊𝐴 =
𝑊𝑊−𝑊𝑑
𝑊𝑑
∙ 100      (3) 
𝑅𝑊 =
𝑊𝑑
𝑊0
∙ 100      (4) 
Where Ww, Wd and W0 are wet (obtained immediately after wiping films with a filter paper), 
dry (obtained after vacuum-drying at 60 ºC for 24 h) and initial weights, respectively.  
2.7. Differential scanning calorimetry (DSC) 
The thermal behaviour of hydrolytically degraded samples was determined using a Mettler 
Toledo DSC 822e calorimeter under nitrogen atmosphere (30 mL/min). Before thermal 
characterization, DSC temperature and enthalpy calibrations were performed using indium as 
standard (with an instrument accuracy of ±0.2 K). Samples were sealed in an aluminium pan 
and heated from -20 ºC to 200 ºC at a rate of 10 ºC/min to determine the thermal transitions 
(Tg, ΔHcc and ΔHm). The crystalline fraction Xc (%) attributable to the PLLA crystallization 
during the corresponding heat treatment was determined as follows: [36] 
𝑋𝑐(%) =
∆𝐻𝑓−∆𝐻𝑐
∆𝐻𝑓
0 ∙ 𝑊𝑚
∙ 100                                        (5) 
where ΔHf and ΔHc are respectively the enthalpy of fusion and cold crystallization of the 
samples determined on the DSC and Wm is the PLLA matrix weight fraction in the composite 
sample. ΔHf
0 = 106 J/g was taken as the heat of fusion of an infinitely thick PLLA crystal. [37] 
2.8. Flame atomic absorption spectroscopy (FAAS) 
Zinc concentration in the degradation medium was determined in a Perkin Elmer Analyst 800 
flame atomic absorption spectrometer by FAAS using an oxidizing air/acetylene flame by 
measuring the absorbance at 213.9 nm. The amount of expeled Zn was calculated by 
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interpolation of the obtained absorbance values during the calibration curves (a standard Zn 
solution was employed for the construction of calibration curves). 
2.9. Surface Zeta-potential measurement 
Zeta-potential measurements based on Fairbrother-Mastin algorithm, which takes into 
account the conductivity of the employed electrolyte,
[38]
 were performed using a 
commercially available Electrokinetic Analyzer for Solid Surface Analysis: SurPASS from 
Anton Paar GmbH (AT). Surface zeta potential (ζ) was measured at RT and a maximum 
pressure of 200 mbar using a 0.001 mol∙dm−3 KCl electrolyte. 
 
2.10. Cell culture 
Murine C2C12 myoblasts at passage 3 were maintained in growth medium (Dulbecco’s 
modified Eagle’s medium (DMEM 4.5 g/L glucose + L-pyruvate, Gibco, MA, US) 
supplemented with 20% Foetal Bovine Serum (FBS, Gibco) and 1% Penicillin/Streptomycin) 
until seeding. Prior seeding, samples were sterilized by sonication immersing them in ethanol 
for 30 min. Glass coverslips were UV treated for 30 min.  
2.11. Cell adhesion assay 
Cell adhesion assay was carried out seeding C2C12 cells at 5000 cells/cm
2
 in serum-free 
medium for 3 h (37 °C, 5% CO2), in order to direct the adhesion to the protein coating. 
Protein coating was performed by adsorption of fibronectin (R&D Systems (UK), 20 µg/mL) 
for 1h at RT and then washing them twice with Dulbecco’s Phosphate Buffered Saline 
(DPBS, Gibco). After 3 h of culture cells were fixed with 4% formaldehyde for 1 h at 4 °C 
and maintained in DPBS until further analysis. Glass coverslips coated with fibronectin (20 
µg/mL, 1 h at RT) were used as controls. 
2.12. Vinculin immunostaining 
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Samples were incubated in permeabilising buffer (0.5% Triton X-100 (Sigma, UK) in 20 mM 
HEPES buffer (Sigma) supplemented with 0.3 M sucrose, 50 mM NaCl (Sigma) and 3 mM 
MgCl2 (Scharlab, ES)) for 5 min, and subsequently blocked in 1% bovine serum albumin 
(BSA, Gibco) for 1 h at RT. The primary monoclonal antibody hVIN-1 (Sigma) against 
vinculin was incubated for 1 h at RT (dilution 1:400) and washed three times in DPBS + 
0.5% tween 20. Then, the secondary antibody Cy3 antimouse (Jackson Immunoresearch, US, 
dilution 1:200) was added with Phalloidin (Invitrogen (UK)), Dilution 1:300) to stain the 
actin cytoskeleton and were incubated for 1 h at RT. The secondary antibody was washed 
three times in DPBS + 0.5% Tween 20; finally, samples were mounted using mounting 
medium with DAPI (Vectashield-DAPI, Vector laboratories, US).  
2.13. Viability test 
Viability tests were performed seeding C2C12 cells at a density of 5000 cells/cm
2
 in growth 
medium for 24 h, 3 d and 7 d. A mammalian LIVE/DEAD
®
 assay (Invitrogen) was carried 
out at each selected time following the recommendations of the manufacturer. Briefly, 
samples were washed with DPBS and incubated with 4 µM of Ethidium homodimer-1 and 2 
µM of calcein-AM for 30 min at 37 °C in darkness conditions. Finally, samples were 
mounted with mounting medium without DAPI (Vectashield) and different images were 
taken for quantification. Glass coverslips were used as controls. 
2.14. Differentiation assay 
Differentiation assay was assessed seeding C2C12 cells at 20000 cells/cm
2
 in differentiation 
medium (Dulbecco’s modified Eagle’s medium (DMEM 4.5 g/L glucose + L-pyruvate) 
supplemented with 1% ITS-X (Insulin-transferrin-selenium-ethanolamine, Gibco) for 4 days, 
changing the medium the second day of culture. At the fourth day cells were fixed with 70% 
ethanol, 37% formaldehyde and glacial acetic acid at 10:1: 0.5 (V/V/V) ratio for 1 h at 4 °C, 
and subsequently stained for sarcomeric myosin. Prior to the seeding, samples were coated 
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with 10 µg/mL of fibronectin to facilitate cell attachment. Glass coverslips coated with both 
collagen (1 mg/mL, 1 h at RT) and then fibronectin (10 µg/mL, 1 h at RT) were used as 
positive controls.  
2.15. Sarcomeric myosin immunostaining 
Previous fixed cells were washed twice with DPBS. After washing, samples were blocked 
with blocking buffer (5% Goat Serum in DPBS) for 1 h at RT. The primary antibody anti-
sarcomeric myosin (MF-20, Developmental Studies Hybridoma Bank, US) was used at a 
dilution 1:200 in blocking buffer for 1 h at RT. Then, samples were washed three times with 
DPBS + 0.5% tween 20 and blocked again with blocking buffer for 10 min at RT. After 
blocking, samples were washed twice with DPBS + 0.5% tween 20 and the secondary 
antibody rabbit anti-mouse Cy3 (Jackson Immunoresearch) was added at a dilution 1:250 in 
blocking buffer for 1 h at RT in darkness conditions. Finally, samples were washed three 
times with DPBS + 0.5% tween 20 and mounted with mounting medium (Vectashield-
DAPI).  
2.16. Proliferation assay 
Myoblasts C2C12 were seeded (5000 cells/cm2) on PLLA and PLLA/ZnO nanocomposites 
for two weeks using growth medium. The measurement of cell density was carried out 
through an AlamarBlue® (BioRad, UK) assay following manufaturer’s recommendations. 
Briefly, 10% of AlamarBlue® was added at each time point to the culture medium for 3 h and 
then, the reduced product was measured by fluorescence in a plate reader at Ex/Em 560/590 
nm with a manual gain of 72. A calibration curve was also assessed in order to correlate 
fluorescence intensity with cell density. 
2.17. Image analysis  
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Cell adhesion assay images were analysed from the fluorescence images taken with a Zeiss 
Observer Z.1 microscope (Carl Zeiss, DE). Three different channels were acquired: blue for 
DAPI, green for phalloidin (actin cytoskeleton) and red for Cy3 (vinculin). Vinculin images 
were uploaded to the Focal Adhesion Analysis Server 
[39]
 using the actin cytoskeleton as cell 
mask. The images of binarized focal adhesions were measured using the Analyze particles 
tool in ImageJ (ImageJ 1.5b, National Institutes of Health (NIH)). Phalloidin images were 
used as well to study the morphology of cells (n > 50 cells).   
Images from the LIVE/DEAD
®
 assay were taken in order to count the number of live and 
dead cells. Two channels were acquired: green for calcein-AM (live cells) and red for 
Ethidium homodimer-1 (dead cells). The percentage of viable cells was calculated as the 
number of live cells per total number of cells. 
The differentiation assay was analysed from the fluorescence images taken. Two different 
channels were acquired: blue for DAPI (nuclei) and red for Cy3 (sarcomeric myosin).  DAPI 
images were counted using Find Maxima process (ImageJ) and an image of dots was outlined 
for each nucleus counted. Sarcomeric myosin binarized images were counted and multiplied 
by binarized nuclei images, so only nuclei under myotubes (assigned to differentiated cells) 
were counted. The differentiation percentage was calculated as differentiated cells per total 
number of cells. 
2.18. Fibronectin adsorption quantification on films  
Fibronectin (FN, from human plasma, R&D Systems, UK) was adsorbed onto PLLA or 
PLLA/ZnO from a solution of 20 µg/mL. The adsorption was carried out for 1 h (complete 
saturation) at RT using samples of 10 mm diameter. After that, the supernatant was collected 
and the amount of protein was quantified using a Micro BCA Assay Kit (Thermo Scientific, 
UK) following manufacturer’s instructions. Finally, the amount of FN adsorbed was obtained 
    
13 
 
as the difference between the initial amount and the measured in the supernatant. Glass 
coverslips were used as controls.  
2.19. Enzyme-linked immunosorbent assay (ELISA) 
ELISA was performed on PLLA and PLLA/ZnO coated with FN (20 µg/mL, 1 h at RT) using 
a primary monoclonal antibody HFN7.1 (Developmental Studies Hybridoma Bank, IA, US) 
and a HRP-Goat Anti-Mouse (Invitrogen, CA, US) secondary antibody, coupled with a 
horseradish peroxidase for colorimetric detection. Controls without FN coatings were used as 
blank for each material. Samples were washed with DPBS twice, transferred to multiwell 
plates and blocked with BSA 1% for 30 min at RT. After that, samples were incubated with 
the primary antibody (1 h, RT, dilution 1:330) and washed twice with DPBS + tween 20 
0.05%. The secondary antibody was then added (1 h, RT, dilution 1:10000) in dark 
conditions and washed twice with DPBS + tween 20 0.05%. Samples were transferred to a 
new multiwell plate and the substrate reagent (colour reagents A and B from R&D Systems, 
MN, US) was added (20 min, RT) in dark conditions. After substrate incubation, the reaction 
was stopped with a stop solution (R&D Systems) and transferred to a 96-well plate to read 
the absorbance at 450 and 540 nm. 
 
2.20. Statistical analysis 
The statistical analysis was assessed using GraphPad Prism 6.01. All values are expressed as 
mean ± SD and the number of replicates are specified for each assay. Parametric (ANOVA or 
t-test for homoscedastic data) and non-parametric (Kruskal-Wallis test when heteroscedastic 
data) tests were used depending on the experiment.  
3. Results and discussion 
3.1. Morphological characterization 
    
14 
 
Transmission electron microscopy (TEM) was used to determine the morphology of the ZnO 
nanoparticles. TEM micrographs (Figure 1a) confirmed the nanometric rod-shaped structure 
of the NPs, with ~20 nm width and ~43 nm length (particle size-distribution determined from 
10 TEM images). Additionally, wide angle X-ray diffraction pattern (Supporting Information, 
Figure S1) showed featured reflections of the hexagonal Wurtzite crystal system. 
 
It is well established that the nanoparticle dispersion within the polymeric matrix plays a key 
role on the physical properties of the material, which in turn influences the resulting 
cell/material interaction. [8, 9] In this sense, both bulk and surface nanoparticle dispersion were 
evaluated by field emision scanning electron microscopy (FE-SEM) and atomic force 
microscopy (AFM) respectively. Figure 1b shows a representative FE-SEM micrograph of 
cryogenically fractured PLLA/ZnO 1 wt.% nanocomposite surface, where nanoparticles  can 
be observed homogeneously distributed throughout the polymer matrix. Figure 2a and 2d 
display the surface features of initial non-degraded neat PLLA and PLLA/ZnO film 
respectively. Rq and Ra surface roughness parameters, which quantitatively determine the 
average vertical deviation of the surface profile from the center plane, [40] are included.  
Images reveal that surface topology is slightly modified by ZnO NPs whereas the neat 
polymer shows a corrugated surface, nanocomposites present a flat surface with prominent 
ZnO nanoparticles. However, similar values of surface roughness were measured on both 
PLLA and the nanocomposite, which suggests that the overall topography of the surface does 
not change by the presence of the NPs, as previously reported for other PLLA based 
nanocomposites. 
[9]
 
3.2. Hydrolytic degradation of films at 37 °C 
 PLLA/ZnO nanocomposites were hydrolytically degraded at 37 ºC for 15 days. The extent of 
hydrolytic degradation was followed by differential scanning calorimetry (DSC, Figure S2), 
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pH changes, water absorption (WA) and remaining weight (RW) measurements (Table 1). 
After 8 days, the crystallinity (Xc) of neat PLLA specimens slightly increases from 12.1% to 
19.3% whereas the Xc increase is more noticeable on the nanocomposites (from 13.2% to 
47.3%) as degradation proceeds, likely due to the presence of nanoparticles that act as 
catalytic nuclei to prompt the hydrolytic degradation of the PLLA polymer. Moreover, a 
decrease was observed in the cold crystallization temperature (Tcc) in both specimens. This 
effect is ascribed to the progressive chain-shortening via random-scission of ester linkages, 
[41]
 which increases the chain mobility and boosts the development of highly-ordered 
crystalline phases. 
[42]
  
The pH evolution of the medium gives further insights about the hydrolytic degradation of 
specimens; a pH decrease would indicate a release of acidic by-products from the material to 
the medium. The fact that pH, together with remaining weight (RW) and water absorption 
(WA), remains almost stable after 8 days denotes the absence of large amounts of carboxylic 
end-groups arising from the hydrolytic degradation of PLLA. After 15 days, Table 1 shows 
more changes that suggest a higher progress of degradation on the PLLA/ZnO system in 
comparison to neat PLLA. This result is in accordance with recent studies that show ZnO 
nanoparticles as accelerators of the hydrolytic degradation of PLLA in water at temperatures 
below Tg. 
[43]  
 
Figure 2 depicts AFM height and phase images of both neat PLLA and ZnO-loaded PLLA 
upon hydrolytic degradation at 37 ºC. The corrugated surface of PLLA becomes smoother as 
time goes by, quantified by the decrease in the overall Rq from 43.2 nm to 21.5 nm (Figure 2 
and Figure 3b). However, degradation of PLLA/ZnO involves significant local topological 
changes on the surface, with the formation of nanoscale pits throughout the sample and Rq 
increasing from 32.1 nm to 132 nm after 15 days. This behaviour is related to the degradation 
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of PLLA surrounding ZnO nanoparticles. The phase image suggests that NPs remain on the 
surface after 15 days, but are not covered by a polymer layer (Figure 2). Note that long-term 
degradation of the system could lead to a complete ejection of the NPs, which can be 
internalized by cells, generating ROS and inducing cytotoxicity. [29] However, the degradation 
of PLLA can be tuned to prevent these unwanted effects in a broad time window. [44-46] This is 
interesting not only to avoid a possible long-term cytotoxicity but also to control when the 
NPs are exposed on the surface of PLLA.  
 
We have also determined the amount of zinc released into the supernatant as a function of 
time by flame atomic absorption spectroscopy (FAAS), a technique especially suitable for the 
accurate quantification of heavy metals. [47, 48] Results show that films release an average zinc 
concentration of 5 ng/mm2 after 8 days and 6.5 ng/mm2 (~ 3 µM) after 15 days (Figure 3). 
Those results are in accordance with AFM morphological characterizations where the 
development of craters surrounding ZnO nanoparticles are observed, with most of the 
particles still on the surface (Figure 2). The reported cytotoxic zinc concentration, using 
different cell types, in culture is 150 µM, 
[32]
  which suggests that the amount of zinc released 
in our system is slow enough to not create adverse cellular effects due to the presence of zinc. 
In the light of obtained FAAS results, together with data shown in Table 1 and AFM images, 
a model depicting ZnO release to the medium is shown in Figure 3, where the cross-section 
of PLLA/ZnO nanocomposite is shown in grey and ZnO nanoparticles are depicted as thick 
blue bars. When the hydrolytic degradation of PLLA starts (white line) only a small fraction 
of NPs on the surface is not covered by PLLA as confirmed by FE-SEM and AFM (Figure 1 
and Figure 2), with similar measurements of roughness for both  PLLA and PLLA/ZnO 
(Figure 3b). As degradation of PLLA proceeds, NPs are continuously exposed on the surface 
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(after ~ 8 days) and finally only a few of them are released into the medium after 15 days of 
hydrolytic degradation (Figure 3b, small amounts of zinc detected by FAAS). 
 
 
3.3. Cell culture studies 
3.3.1. Biocompatibility, cell adhesion and morphology  
We first wanted to disregard the potential cytotoxicity of the system – some authors have 
reported that ZnO might be cytotoxic under certain conditions – [31-33] using a LIVE/DEAD® 
assay. To do so, C2C12 were seeded onto the surfaces with growth medium for 1 week. 
Figure 4a shows the LIVE/DEAD® staining at 1, 3 and 7 days of culture for PLLA/ZnO. 
Viability of C2C12 myoblasts on the PLLA/ZnO nanocomposite was ~ 99% after 7 days, 
similar to the negative control (Figure 4b). In this experiment cells are in direct contact with 
the surface of the material, which suggests the lack of release of any cytotoxic compound. 
Taking into account the data obtained by FAAS, in which a total zinc release of 5 ng/mm2 at 8 
days was observed, it is reasonable to think that the small release detected was not cytotoxic. 
These results are in accordance with other studies that estimated the minimum ZnO NP 
concentration that causes the inflammation response in endothelial cells to be 10 µg/mL (~ 
150 µM), 
[33] which is 50 times the concentration of Zn measured in our system. From the 
images, we also quantified cell density (Figure 4c) that increased linearly as a function of 
time. The number of cells was higher on the nanocomposite, but not significant.  
Afterwards, we investigated initial cell adhesion and spreading on the nanocomposites. Cells 
interact with synthetic surfaces through a layer of adsorbed proteins, on which cells adhere 
and spread before other cellular processes such as cell proliferation or differentiation occur. 
We first studied the behaviour of FN on the material surfaces. We selected FN because it is 
one of the major constituents of the extracellular matrix and presents a promiscuous cell-
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attachment sequence (the RGD sequence) that can be recognised by multiple integrins.[49] We 
quantified the amount of adsorbed FN and the conformation via the availability of RGD 
domains using a monoclonal antibody (HFN7.1) against the region between the 9th and 10th 
FN-type III repeating domains in which the RGD sequence resides. [50] Figure 4d shows the 
surface density of fibronectin (ng/cm2) that was significantly higher on PLLA/ZnO than 
PLLA. Figure 4e shows higher availability of RGD on fibronectin adsorbed onto 
PLLA/ZnO. Normalisation of Figure 4e, using the amount of FN on the surface (Figure 4f), 
results in no differences between material systems. This is likely a consequence of the higher 
amount of protein initially adsorbed onto the PLLA/ZnO, as opposed to PLLA, rather than 
any differences in FN conformation.  
 Cell morphology after 3 h of culture was very similar, and cells presented a well-developed 
actin cytoskeleton with tension fibres (Figure 4g) typical of cells cultured on 2D rigid 
substrates [51] (stiffness measured via indentation with the AFM was 3.417 ± 1.037 GPa for 
PLLA and 3.027 ± 0.760 GPa for PLLA/ZnO, Figure S3). Cell shape descriptors were 
calculated and shown in Figure 4h. Cell area, perimeter, roundness and circularity were 
similar between cells adhered on PLLA, PLLA/ZnO or glass control meaning that cells were 
well spread. Figure 5a and Figure S4 show focal adhesions after 3 h studied via vinculin 
immunostaining. Interestingly, cells on PLLA/ZnO developed a higher number of focal 
adhesions (FA) than on PLLA (total FA count per cell, Figure 5c) and the area of the FA was 
significantly higher in PLLA/ZnO than pure PLLA. In addition, the distribution of the FA 
area shows the presence of a higher number of mature focal adhesions on the nanocomposite 
than the bulk polymer, including FAs bigger than 3 µm2 (Figure 5b). The presence of the 
higher number and larger FAs on the nanocomposite, compared to neat PLLA, correlates with 
the surface density of fibronectin measured and thus with the presence of a higher number of 
RGD domains available for cell interaction. 
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It is well known that surface charge influence protein adsorption.[52, 53]  To study whether the 
initial amount of adsorbed fibronectin on PLLA/ZnO was due to differences in the initial 
superficial charges of the surfaces, we measured the Z-potential. However, similar values 
were obtained for both surfaces, -30.20 ± 0.75 mV - PLLA and -33.07 ± 3.65mV - 
PLLA/ZnO, which disregards the possible effect of surface charge on the higher protein 
adsorption measured on the nanocomposite.  
3.3.2. Cell proliferation and differentiation 
We then analysed the ability of C2C12 cells to proliferate and differentiate on the 
nanocomposites. Figure 6d shows the proliferation curve obtained by means of an 
AlamarBlue® assay using neat PLLA and the ZnO nanocomposites for two weeks. At day 1 
and 4 the number of cells was the same between materials, although the PLLA/ZnO 
nanocomposite presented lower proliferation rate at this time of culture. After one week, the 
number of cells increased, with the highest number of cells on the nanocomposites. During 
this week a typical plateau was observed, suggesting that cells reached confluence; therefore, 
at day 10 the number of cells quantified was similar to day 7 and, after 2 weeks the number of 
cells started to decrease, due to cell death from contact inhibition processes. It is interesting 
to note that cells seeded onto PLLA reached confluence at day 4, while on PLLA/ZnO 
nanocomposites continued growing. Nevertheless, differences observed were not statistically 
significant, which suggests that the release of zinc ions at this time was not enough to 
enhance cell proliferation, as has been suggested to happen with zinc concentrations within 
25-50 µM.[26]  
Myoblast differentiation was assessed by staining for sarcomeric myosin that, together with 
multinucleated myotube formation, is characteristic of the differentiation process (Figure 6b, 
e). Four days is the standard time required for C2C12 in vitro differentiation studies with 
myogenic differentiation medium; after that time, the percentage of differentiation was 
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similar between PLLA and PLLA/ZnO (Figure 6c). Moreover, at this time the amount of zinc 
released from the system to the medium is low (Figure 3c) and the hydrolytic degradation 
occurred is not enough to expose the nanoparticles on the surface; therefore, the changes in 
roughness at this point are also negligible. However, after two weeks of culture, 
differentiation was up to 30% higher on the nanocomposite than on neat PLLA (note that this 
was done in standard medium with 20% FBS, i.e. no soluble cues added) (Figure 6f). As can 
be seen on Figure 6e, mature, multinucleated myotubes were formed on the nanocomposite 
with larger area and thickness (~ 40 µm2 area and > 40 µm thickness). The calculated fusion 
index, the number of nuclei per myotube, was consequently higher on the nanocomposite 
with more than 40% of myotubes containing ≥ 6 nuclei, whereas 40% of cells on PLLA 
presented only one nucleus (no fusion) (Figure 6g). This different cellular behaviour between 
PLLA and PLLA/ZnO was enhanced as a function of time (i.e. 4 d versus 14 d), which is 
correlated to the degradation of the superficial layer of PLLA and the appearance of ZnO 
nanoparticles on the material surface.  
The dynamic presence of NPs alters different parameters such as surface roughness and the 
release of Zn into the culture medium.  Changes in roughness do not seem to be a trigger of 
C2C12 differentiation; for example, stiff and smooth surfaces were found to favour C2C12 
differentiation.[54] In addition, organised topographical patterns do not influence C2C12 
differentiation compared to flat ones. [55, 56]  Conversely, the release of zinc into the culture 
medium, as PLLA degradation proceeds, is very low compared to the amounts needed to 
promote C2C12 differentiation (~ 3 µM in our system), which is further diluted due to the 
periodical changes of the medium during culture, compare to 25-50 µM. [26]  
For cell differentiation to occur, cells have to leave the cell cycle and hence, stop 
proliferation. After 4 days, the combination of the differentiation medium and the surface of 
PLLA are the modulators of myoblast differentiation, as it has been shown previously,[57] i.e. 
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there is no evident effect of the nanoparticles in cell differentiation. However, by maintaining 
a growing cell population longer, they leave the cell cycle triggered by the stimuli coming 
from the material system, as more nanoparticles are available on the material surface as 
PLLA degrades. [41, 42] Note that in this case the degradation rate could be essential in order to 
see differences in the percentage of differentiation and this can be easily tuned in PLLA.[44, 45]  
 
4. Conclusions 
In this work, we have engineered and characterised ZnO nanoparticle–loaded PLLA 
degradable system, with nanoparticles homogeneously dispersed on the PLLA surface. The 
availability of ZnO particles during the degradation of PLLA induces the formation of 
nanopits, containing particles, on the surface. Based on the low amount of released Zn 
compared to the amount of Zn necessary to trigger C2C12 differentiation, as well as the AFM 
images, the initial similar Z-potential and Young’s modulus measured, we concluded that the 
availability of the ZnO NPs, as PLLA degrades on the material surface, is the cue for cell 
differentiation. In standard conditions, C2C12 myoblasts differentiate within 4 days as long 
as the adequate stimuli is provided. Surprisingly, our results show that only when PLLA 
degradation starts, after ~ 15 days, is cell differentiation significantly enhanced, which is 
correlated with the presence of NPs on the material surface. The system can be further 
engineered to control the degradation rate of PLLA and subsequently the timescale at which 
NPs are available on the material surface, which provides different cues for cell growth 
versus differentiation. Further biological studies are necessary to determine how the presence 
of NPs on the surface trigger signalling pathways, leading to myogenesis. 
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Captions to Figures 
Figure 1. Morphological characterization of nanocomposites. (a) TEM image showing the 
structure of ZnO nanoparticles at a 230.000x magnification; (b) FE-SEM micrographs 
showing ZnO dispersion (e.g. arrows) in PLLA matrix. 
Figure 2. AFM height and phase images showing surface features of neat PLLA and 
PLLA/ZnO nanocomposite. (a) The initially non-degraded matrices (0 d) and (b, c) 8-15 days 
degraded surfaces are shown; roughness values are highlighted. Scale bar: 2 µm. 
 
Figure 3. Hydrolytic degradation mechanism. (a) Schematic representation of hydrolytic 
degradation in PLLA/ZnO nanocomposites, (b) Average roughness during hydrolytic 
degradation of PLLA and PLLA/ZnO nanocomposites and (c) representation of released mass 
of Zn per unit area measured by FAAS (± SD FAAS).   
Figure 4. (a) C2C12 cells were grown for 7 days in growth medium onto PLLA/ZnO films 
and a LIVE/DEAD staining was assessed at 1, 3 and 7 days. Living cells are shown in green 
and dead cells in red. Scale bar: 50 µm. (b) Percentage of cell survival (mean ± SD) from the 
LIVE/DEAD staining and (c) cell density at 7 days (mean ± SD); (d) surface density after 
fibronectin adsorption for 1 h (ng/cm2) (n = 3), (e) availability of the RGD sequence of the 
adsorbed fibronectin on the surfaces measured by ELISA (plotted as absorbance at 450 - 
absorbance at 540 nm) (n = 3), (f) normalized absorbance with the amount of fibronectin 
quantified in (d). (g) C2C12 actin cytoskeleton (green) and nuclei (blue) at 3 h culture (scale 
bar: 50 µm); (h) shape descriptors were quantified from 3 h culture (mean ± SD, n > 50), 
Roundness = 4[area]/π[major axis]2, Circularity = 4π [area]/[perimeter]2. Statistical 
differences in an unpaired t-test (*) p-value < 0.05, (***) p-value < 0.001. Glass coverslips 
were used as controls.  
Figure 5. Focal adhesion analysis. (a) Representative binary images of the focal adhesions 
(FA) (scale bar: 25 µm), (b) Distribution of the focal adhesion areas (µm2); (c) Focal 
adhesion count per cell analysed (n = 10, mean ± SD), (d) median of the focal adhesion areas 
(µm2) (n = 10, mean ± SD), (e) median of the focal adhesion size (µm) (n = 10, mean ± SD). 
Statistical differences using ANOVA test with a Tukey’s post hoc test are shown as *** p-
value < 0.001. Glass coverslips were used as controls.  
Figure 6. Cell proliferation and cell differentiation. (a) Sketch showing the differences 
between the assays performed. C2C12 cells were culture on PLLA or PLLA/ZnO for 4 d with 
differentiation media or C2C12 cells were culture on PLLA or PLLA/ZnO for 14 d with 
growth media. (b) Representative images of sarcomeric myosin immunostaining (green) and 
DAPI (red) are presented at 4 d with differentiation media (scale bar: 200 µm) and (c) 
percentage of differentiation was calculated at 4 d as number of cells differentiated per total 
number of cells. (d) C2C12 proliferation curves (cells/cm2) during 2 weeks of culture in 
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growth medium. (e) Representative images for sarcomeric myosin and DAPI at 14 d of 
culture with growth media (scale bar: 100 µm) and (f) percentage of differentiation was 
calculated at 14 d. (g) Fusion index distribution (number of nuclei per myotube) at 14 d was 
calculated and (h) myotube thickness distribution (µm) at 14 d is also shown. Statistical 
significance was observed in a t-test (***) p-value < 0.001.  
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Tables 
Table 1. Hydrolytic degradation parameters for neat PLLA and PLLA/ZnO 1wt.% 
nanocomposite upon degradation in distilled water. Thermal properties (Xc crystallinity 
degree, Tcc cold crystallization temperature and Tm melting temperature), pH values of the 
degradation medium, water absorption (WA) and remaining weight (RW) (mean ± SD). 
 0 days 8 days 15 days 
PLLA PLLA/ZnO PLLA PLLA/ZnO PLLA PLLA/ZnO 
X
c
 (%) 12±1 13±1 16±2 38±1 19±2 47±3 
T
cc
 (ºC) 102.5±0.9 95.3±1.2  93.1±0.1 79.5±0.5 91.3±1.0 78.1±0.5 
T
m
 (ºC) 174.2±1.0 173.9±0.8  175.8±0.8 171.9±0.9 176.0±0.7 171.1±0.3 
pH 7.40±0.10 7.40±0.10 7.37±0.08 7.36±0.10 7.29±0.12 7.18±0.13 
RW (%) 100 100 99.4±0.7 99.1±0.8 98.6±0.5 98.1±0.8 
WA (%) 0 0 2.3±0.9 9.6±2.1 4.7±0.9 29.4±3.2 
 
 
 
 






